rs753085 — COL27A1

COL27A1 and Vein Wall Integrity — When Your Connective Tissue Scaffold Is Looser

Every vein in your body is held in shape by a scaffold of collagen fibres woven through the vessel wall. Collagen type XXVII — encoded by COL27A1 — is one of the structural proteins in this scaffold. It is a fibrillar collagen first characterised in cartilage, where it organises the pericellular matrix around chondrocytes and guides the transition from cartilage to bone. The same structural role extends to connective tissue elsewhere, including the walls of veins and the sheaths surrounding tendons.

This intronic variant in COL27A1 sits at position 114,283,167 on chromosome 9 (GRCh38). Although it falls within an intron and does not change the amino acid sequence, intronic variants can influence splicing efficiency, transcript abundance, or regulatory element function — all of which alter how much functional collagen a tissue produces.

The Mechanism

COL27A1 encodes the alpha-1 chain of a minor fibrillar collagen. Its triple-helical domain forms long non-banded fibrous structures and thin banded fibrils that contribute tensile strength to the pericellular matrix¹¹ pericellular matrix
the immediate extracellular scaffold surrounding each cell. In venous walls, collagen fibres resist the hydrostatic pressure of blood, maintaining lumen diameter and keeping valve leaflets correctly positioned. When collagen quality or quantity is reduced — whether by a rare pathogenic variant or by a common regulatory variant like rs753085 — the vein wall becomes more compliant, predisposing to dilation, valve incompetence, and eventually varicose veins.

The A allele at rs753085 likely alters COL27A1 splicing or expression through an intronic regulatory element. The precise molecular mechanism has not been characterised for this specific variant, but the GWAS signal at this locus (among 49 signals identified across 46 susceptibility loci in the largest varicose veins study to date) places it firmly within the extracellular matrix pathway that controls venous wall stiffness.

The Evidence

The primary evidence comes from a genome-wide association study of 810,625 individuals²² genome-wide association study of 810,625 individuals
Ahmed et al. Genome-wide association analysis and replication in 810,625 individuals with varicose veins. Nature Communications, 2022 — 135,514 varicose vein cases and 675,111 controls drawn from UK Biobank and 23andMe. The study identified 49 association signals at 46 loci, with biological pathway enrichment in extracellular matrix biology, (lymph)angiogenesis, vascular smooth muscle cell migration, and apoptosis. The COL27A1 locus on chromosome 9 emerged as one of these novel susceptibility signals.

Supporting the connective tissue role of this gene, Saunders et al. (2013)³³ Saunders et al. (2013)
Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations. J Orthop Res, 2013 studied rs753085 alongside three other COL27A1 variants in Achilles tendinopathy cohorts from South Africa and Australia. While no single variant reached individual significance, the broader genomic region containing COL27A1 and tenascin-C showed a significant haplotype association with tendinopathy, reinforcing that COL27A1 variants collectively influence connective tissue integrity across different anatomical sites.

The evidence is categorised as moderate: the GWAS finding is well-powered and biologically coherent, but the specific causal variant and functional mechanism at this locus have not yet been resolved.

Practical Actions

For individuals carrying one or two copies of the A allele, the actionable implications centre on protecting venous wall integrity through factors that support collagen synthesis and reduce venous pressure loading. Vitamin C is the required cofactor for prolyl hydroxylase, the enzyme that cross-links collagen triple helices; without adequate vitamin C, newly synthesised collagen is structurally deficient. Compression stockings directly counteract the venous hypertension that drives varicose vein progression by reducing transmural pressure on the vein wall. Weight management reduces the hydrostatic load on lower-limb veins, and prolonged static standing or sitting — a documented risk factor for varicose veins — should be interrupted with movement.

For carriers with a personal or family history of varicose veins, or who are in occupations involving prolonged standing, earlier consideration of venous ultrasound assessment is appropriate.

Interactions

COL27A1 shares functional overlap with other structural collagen genes including COL3A1 (vascular Ehlers-Danlos syndrome) and COL1A1/COL1A2 (osteogenesis imperfecta, connective tissue laxity). Variants in matrix metalloproteinases (MMP1, MMP3, MMP9) that degrade collagen may compound the effect of reduced COL27A1 expression by accelerating collagen turnover in vein walls. Tenascin-C (TNC), whose gene neighbours COL27A1 on chromosome 9q32, participates in the same extracellular matrix scaffold; combined variation across both genes was shown to influence tendinopathy risk.